Search company, investor...


Founded Year



Seed VC | Alive

Total Raised


Last Raised

$1M | 17 yrs ago

About ChimeraCore

Deliverance of therapeutic drugs directly to the site without risk to healthy tissue.

Headquarters Location

5385 Hollister Avenue Suite 105

Santa Barbara, California, 93111,

United States


Missing: ChimeraCore's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: ChimeraCore's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing ChimeraCore

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ChimeraCore is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

ChimeraCore Frequently Asked Questions (FAQ)

  • When was ChimeraCore founded?

    ChimeraCore was founded in 2004.

  • Where is ChimeraCore's headquarters?

    ChimeraCore's headquarters is located at 5385 Hollister Avenue, Santa Barbara.

  • What is ChimeraCore's latest funding round?

    ChimeraCore's latest funding round is Seed VC.

  • How much did ChimeraCore raise?

    ChimeraCore raised a total of $1M.

  • Who are the investors of ChimeraCore?

    Investors of ChimeraCore include Frontier Venture Capital, New Science Ventures, Gideon Hixon Fund and Arcturus Capital.

  • Who are ChimeraCore's competitors?

    Competitors of ChimeraCore include Hydra Biosciences, Auspex Pharmaceuticals, Revance Therapeutics, BioMimetic Therapeutics, MAP Pharmaceuticals and 13 more.

Compare ChimeraCore to Competitors

OcuNexus Therapeutics

OcuNexus Therapeutics is a development stage biopharmaceutical company that develops treatments for front- and back-of-the-eye diseases and disorders.


Biofisica develops and markets products for soft tissue wound healing and tissue regeneration based on an exclusive and technology that uses electrical stimulation and hydro-gel materials.


AugmentRx has developed a tissue bulking agent to treat stress urinary incontinence. The SOLVE injectable product aims to provide a fully viable alternative to slings, surgical procedures and inferior shorter-acting bulking agents. Per AugmentRx, it is bioinert, non-antigenic, non-migratory, permanent, easy-to-inject, and more affordable and aims to provide long-lasting, sustainable tissue volume.

Radio Therapeutics Corporation

Radio Therapeutics Corporation develops and manufactures radiofrequency-based therapeutic devices for the destruction of various forms of soft tissue tumors. RTC markets the Radiofrequency Ablation System, which uses radiofrequency energy to selectively destroy undesirable soft tissue. The technology is based on hyperthermia (overheating) of the tumor to destroy it with the use of a specially designed probe which is inserted into the tumor. The probe architecture is the core of the technology and permits a localized application of radio-frequency energy. The system is used by radiologists and surgical oncologists for the ablation of nonresectable (inoperable) liver lesions.


Euroflow develop technologies, products and services for the development and production of new therapeutic drugs based on chromatographic techniques, with the aim of bringing new products to market quickly.

FirstString Research

FirstString is a biopharmaceutical company dedicated to discovering therapies for inflammation-based medical conditions.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.